PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19102366-7	2008	CONCLUSIONS: The sustained viral response rate of this pilot study using ribavirin priming and reduced peginterferon dosage is in line with previous trials using standard treatment regimens for chronic hepatitis C. Our data stress the positive impact of the ribavirin-induced TH2-TH1 cytokine shift at least in patients with normal ALT.	Ribavirin	73-82	negative elongation factor complex member C/D	Homo sapiens	280-283	
19102366-7	2008	CONCLUSIONS: The sustained viral response rate of this pilot study using ribavirin priming and reduced peginterferon dosage is in line with previous trials using standard treatment regimens for chronic hepatitis C. Our data stress the positive impact of the ribavirin-induced TH2-TH1 cytokine shift at least in patients with normal ALT.	Ribavirin	258-267	negative elongation factor complex member C/D	Homo sapiens	280-283